Strategic Research Analysis ­ Positioning to Benefit on 

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kroger, Celgene, Twitter, and NIKE ­ Effects of Key Drivers of Growth and Emerging Market Trends

NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abbott Laboratories (NYSE: ABT ), Rite Aid Corporation (NYSE: RAD ), The Kroger Co. (NYSE: KR ), Celgene Corporation (NASDAQ: CELG ), Twitter, Inc. (NYSE: TWTR ), and NIKE, Inc. (NYSE: NKE ) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ABT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ABT

RAD DOWNLOAD: http://Fundamental-Markets.com/register/?so=RAD

KR DOWNLOAD: http://Fundamental-Markets.com/register/?so=KR

CELG DOWNLOAD: http://Fundamental-Markets.com/register/?so=CELG

TWTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=TWTR

NKE DOWNLOAD: http://Fundamental-Markets.com/register/?so=NKE

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  Abbott Laboratories (NYSE: ABT ), Rite Aid Corporation (NYSE: RAD ), The Kroger Co. (NYSE: KR ), Celgene Corporation (NASDAQ: CELG ), Twitter, Inc. (NYSE: TWTR ), and NIKE, Inc. (NYSE: NKE ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples . All information in this release was accessed October 9, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

ABBOTT LABORATORIES (ABT) REPORT OVERVIEW

Certified Factual by Registered Analyst

Abbott Laboratories ' Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Abbott Laboratories reported revenue of $6,637 vs $5,333 (up 24.5%), diluted earnings per share $0.16 vs $0.41 (down 61.0%), and dividends per share $0.265 vs $0.26 (up 1.9%). During fiscal year 2016 vs fiscal 2015, Abbott Laboratories reported revenue of $20,853 vs $20,405 (up 2.2%), diluted earnings per share $0.94 vs $2.92 (down 67.8%), and dividends per share $1.045 vs $0.98 (up 6.6%). Abbott Laboratories is expected to report earnings on 10/18/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $0.65. The reported EPS for the same quarter last year was $0.59.

To read the full Abbott Laboratories (ABT) report, download it here: http://Fundamental-Markets.com/register/?so=ABT

-----------------------------------------

RITE AID CORPORATION (RAD) REPORT OVERVIEW

Certified Factual by Registered Analyst

Rite Aid’s Recent Financial Performance

For the thirteen week period ended June 3, 2017 vs May 28, 2016, Rite Aid reported revenue of $7,781 vs $8,184 (down 4.9%) and diluted earnings per share -$0.07 vs $0.00. During fiscal year 2016 vs fiscal 2015, Rite Aid reported revenue of $30,736 vs $26,528 (up 15.9%) and diluted earnings per share $0.16 vs $2.08 (down 92.3%).

To read the full Rite Aid Corporation (RAD) report, download it here: http://Fundamental-Markets.com/register/?so=RAD

-----------------------------------------

THE KROGER CO. (KR) REPORT OVERVIEW

Certified Factual by Registered Analyst

Kroger's Recent Financial Performance

For the three months ended August 12, 2017 vs August 13, 2016, Kroger reported revenue of $27,597 vs $26,565 (up 3.9%), diluted earnings per share $0.39 vs $0.40 (down 2.5%), and dividends per share $0.125 vs $0.12 (up 4.2%). During fiscal year 2016 vs fiscal 2015, Kroger reported revenue of $115,337 vs $109,830 (up 5.0%), diluted earnings per share $2.05 vs $2.06 (down 0.5%), and dividends per share $0.465 vs $0.408 (up 14.0%).

To read the full The Kroger Co. (KR) report, download it here: http://Fundamental-Markets.com/register/?so=KR

-----------------------------------------

CELGENE CORPORATION (CELG) REPORT OVERVIEW

Certified Factual by Registered Analyst

Celgene’s Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Celgene reported net earnings of $3,268 vs $2,754 (up 18.7%) and diluted earnings per share $1.31 vs $0.75 (up 74.7%). During fiscal year 2016 vs fiscal 2015, Celgene reported net earnings of $11,229.2 vs $9,256.0 (up 21.3%) and diluted earnings per share $2.49 vs $1.94 (up 28.4%). Celgene is expected to report earnings on 10/26/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $1.72. The reported EPS for the same quarter last year was $1.39.

To read the full Celgene Corporation (CELG) report, download it here: http://Fundamental-Markets.com/register/?so=CELG

-----------------------------------------

TWITTER, INC. (TWTR) REPORT OVERVIEW

Certified Factual by Registered Analyst

Twitter's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Twitter reported revenue of $573.86 vs $601.96 (down 4.7%) and diluted earnings per share -$0.16 vs -$0.15. During fiscal year 2016 vs fiscal 2015, Twitter reported revenue of $2,529.62 vs $2,218.03 (up 14.1%) and diluted earnings per share -$0.65- vs -$0.79. Twitter is expected to report earnings on 10/26/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.03. The reported EPS for the same quarter last year was -$0.10.

To read the full Twitter, Inc. (TWTR) report, download it here: http://Fundamental-Markets.com/register/?so=TWTR

-----------------------------------------

NIKE, INC. (NKE) REPORT OVERVIEW

Certified Factual by Registered Analyst

Nike's Recent Financial Performance

For the three months ended February 28, 2017 vs February 29, 2016, Nike reported revenue of $8,432 vs $8,032 (up 5.0%), diluted earnings per share $0.68 vs $0.55 (up 23.6%), and dividends per share $0.18 vs $0.16 (up 12.5%). During fiscal year 2017 vs fiscal 2016, Nike reported revenue of $34,350 vs $32,376 (up 6.1%), diluted earnings per share $2.51 vs $2.16 (up 16.2%), and dividends per share $0.70 vs $0.62 (up 12.9%).

To read the full NIKE, Inc. (NKE) report, download it here: http://Fundamental-Markets.com/register/?so=NKE

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as  Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by GlobeNewswire staff, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: andrew.duffie@fundamental-markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 2

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Crawford Nickel Project Advances Under Ontario's New Framework

Updated Category News Views 90

Introduction to the Crawford Nickel Project Canada Nickel Company Inc. has exciting news regarding its Crawford Nickel Project, which has been officially recognized by the Province of Ontario. This milestone comes as part of Ontario's One Project, One Process (1P1P) framework, a major step forward for the mining sector. Understanding the One Project, One Process Framework...

Continue Reading
TeamBridge Secures $28 Million to Enhance Workforce Technology

Updated Category News Views 124

TeamBridge Secures $28 Million to Revolutionize the Hourly Workforce TeamBridge, a rapidly expanding Workforce Operating System (Workforce OS), has successfully raised $28 million in Series B funding. This round was led by Mayfield, with considerable backing from existing investors, including General Catalyst and Abstract Ventures. This funding represents a significant...

Continue Reading
Innovative AI Collaboration for Breakthrough Cancer Therapies

Updated Category News Views 116

Pierre Fabre Laboratories and Iktos Unite for Oncology Drug Discovery Pierre Fabre Laboratories and Iktos have announced an exciting new collaboration aimed at transforming drug discovery in oncology. This partnership harnesses the strengths of both companies to utilize advanced AI technologies for developing new small-molecule drug candidates. Together, they plan to make...

Continue Reading
Vitamin Angels Partners with Walgreens to Improve Lives Globally

Updated Category News Views 529

Vitamin Angels and Walgreens: A Transformative Partnership Vitamin Angels and Walgreens have reached a remarkable achievement, positively impacting the lives of 500 million women and children across the globe. Over the course of their partnership, they have dedicated themselves to providing essential vitamins and minerals primarily to underserved communities within the...

Continue Reading
Forecasting the Growth of India's Flourishing Fluoropolymer Market

Updated Category News Views 104

Understanding the Flourishing Fluoropolymer Market in India India's fluoropolymer market is on an impressive trajectory, forecasted to reach a valuation of US$ 799.28 million by 2033 from US$ 425.12 million in 2024, reflecting an annual growth rate (CAGR) of 7.46% during the years ahead. This surge can be attributed to various factors, including technological...

Continue Reading